• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国新诊断 HIV/AIDS 成人患者中高血糖的患病率。

Prevalence of hyperglycemia among adults with newly diagnosed HIV/AIDS in China.

机构信息

Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.

出版信息

BMC Infect Dis. 2013 Feb 11;13:79. doi: 10.1186/1471-2334-13-79.

DOI:10.1186/1471-2334-13-79
PMID:23394285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3574853/
Abstract

BACKGROUND

The prevalence of hyperglycemia among HIV-infected persons who are not receiving antiretroviral therapy is unknown. We conducted a cross-sectional survey to estimate the prevalence of hyperglycemia among Chinese adults with newly diagnosed HIV/AIDS.

METHODS

Two thousand and six newly diagnosed HIV/AIDS patients from 10 provinces and municipalities in China were selected during 2009 to 2010. After an overnight fast, serum samples were collected to measure glucose concentrations. Demographics and medical histories were recorded. Factors associated with the presence of diabetes were analysed by logistic regression.

RESULTS

Among the 2006 patients, 75.67% were male. Median age was 40 years (range: 18-86 years). 19.99% had hyperglycemia, 9.47% had impaired fasting glucose (IFG) and 10.52% had diabetes. The prevalences of hyperglycemia, of IFG and of diabetes were 21.54%, 10.28% and 11.27% among men and 15.16%, 6.97% and 8.20% among women, respectively. The prevalence of diabetes increased with increasing age (7.00%, 13.36% and 21.21% among patients who were 18-40, 40-60, and ≥60 years of age respectively) and with decreasing CD4 count (6.74%, 8.45%, 9.69%, and 12.66% among patients with CD4 count of ≥350, 200-350, 50-200, and < 50/mm3 respectively). The prevalence of diabetes was higher among ethnic minority patients than among the Han patients (14.37% versus 9.24%). The logistic analysis showed that older age, lower CD4 count and minority ethnicity were significantly associated with an increased risk of diabetes.

CONCLUSIONS

Hyperglycemia is highly prevalent among Chinese adults with newly diagnosed HIV/AIDS. Older age, lower CD4 count and minority ethnicity are associated with increased risk of diabetes. All newly diagnosed HIV/AIDS individuals should be routinely evaluated for hyperglycemia.

摘要

背景

未接受抗逆转录病毒治疗的 HIV 感染者中高血糖的患病率尚不清楚。我们进行了一项横断面调查,以估计中国新诊断 HIV/AIDS 成人中高血糖的患病率。

方法

2009 年至 2010 年期间,我们从中国 10 个省和直辖市选择了 2006 例新诊断的 HIV/AIDS 患者。空腹过夜后,采集血清样本测量血糖浓度。记录人口统计学和病史。采用 logistic 回归分析与糖尿病存在相关的因素。

结果

在 2006 例患者中,75.67%为男性。中位年龄为 40 岁(范围:18-86 岁)。19.99%有高血糖,9.47%有空腹血糖受损(IFG),10.52%有糖尿病。男性高血糖、IFG 和糖尿病的患病率分别为 21.54%、10.28%和 11.27%,女性分别为 15.16%、6.97%和 8.20%。糖尿病的患病率随年龄增长而增加(18-40 岁、40-60 岁和≥60 岁的患者分别为 7.00%、13.36%和 21.21%),随 CD4 计数减少而增加(CD4 计数≥350、200-350、50-200 和<50/mm3 的患者分别为 6.74%、8.45%、9.69%和 12.66%)。少数民族患者的糖尿病患病率高于汉族患者(14.37%比 9.24%)。logistic 分析显示,年龄较大、CD4 计数较低和少数民族与糖尿病风险增加显著相关。

结论

中国新诊断 HIV/AIDS 成人中高血糖患病率很高。年龄较大、CD4 计数较低和少数民族与糖尿病风险增加相关。所有新诊断的 HIV/AIDS 患者均应常规评估高血糖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7092/3574853/2bf500099f7e/1471-2334-13-79-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7092/3574853/96e438a74c1b/1471-2334-13-79-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7092/3574853/ba9dd32660fb/1471-2334-13-79-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7092/3574853/f79a8ab64b2a/1471-2334-13-79-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7092/3574853/2bf500099f7e/1471-2334-13-79-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7092/3574853/96e438a74c1b/1471-2334-13-79-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7092/3574853/ba9dd32660fb/1471-2334-13-79-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7092/3574853/f79a8ab64b2a/1471-2334-13-79-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7092/3574853/2bf500099f7e/1471-2334-13-79-4.jpg

相似文献

1
Prevalence of hyperglycemia among adults with newly diagnosed HIV/AIDS in China.中国新诊断 HIV/AIDS 成人患者中高血糖的患病率。
BMC Infect Dis. 2013 Feb 11;13:79. doi: 10.1186/1471-2334-13-79.
2
Prevalence of anemia among adults with newly diagnosed HIV/AIDS in China.中国新诊断为 HIV/AIDS 的成年人贫血患病率。
PLoS One. 2013 Sep 18;8(9):e73807. doi: 10.1371/journal.pone.0073807. eCollection 2013.
3
Analysis of the immunologic status of a newly diagnosed HIV positive population in China.中国新诊断的HIV阳性人群免疫状态分析。
BMC Infect Dis. 2013 Sep 11;13:429. doi: 10.1186/1471-2334-13-429.
4
A cross-sectional study of leukopenia and thrombocytopenia among Chinese adults with newly diagnosed HIV/AIDS.一项横断面研究:中国新诊断 HIV/AIDS 成人患者的白细胞减少症和血小板减少症。
Biosci Trends. 2015 Apr;9(2):91-6. doi: 10.5582/bst.2015.01024.
5
Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus Among HIV Positive Patients in Tehran, Iran.伊朗德黑兰HIV阳性患者中高血糖和糖尿病的患病率及相关危险因素
Infect Disord Drug Targets. 2019;19(3):304-309. doi: 10.2174/1871526518666180723152715.
6
[An analysis of factors associated with timeliness of antiretroviral therapy initiation among newly diagnosed HIV/AIDS from 2010 to 2014 in China].[2010年至2014年中国新诊断的HIV/AIDS患者中与抗逆转录病毒治疗启动及时性相关因素的分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2017 Aug 6;51(8):711-717. doi: 10.3760/cma.j.issn.0253-9624.2017.08.010.
7
Prevalence and predictors of anaemia in patients with HIV infection at the initiation of combined antiretroviral therapy in Xinjiang, China.中国新疆地区接受联合抗逆转录病毒治疗初始阶段的HIV感染患者贫血症的患病率及预测因素
Int J STD AIDS. 2015 Mar;26(3):156-64. doi: 10.1177/0956462414531935. Epub 2014 May 8.
8
[The prevalence and relevant factors of hyperglycemia in AIDS patients receiving antiretroviral therapy in a single center].[单中心接受抗逆转录病毒治疗的艾滋病患者高血糖的患病率及相关因素]
Zhonghua Nei Ke Za Zhi. 2014 Jun;53(6):446-9.
9
Baseline CD4 cell counts of newly diagnosed HIV cases in China: 2006-2012.2006 - 2012年中国新诊断艾滋病病毒病例的基线CD4细胞计数
PLoS One. 2014 Jun 5;9(6):e96098. doi: 10.1371/journal.pone.0096098. eCollection 2014.
10
Severe hyperglycemia in an HIV clinic: preexisting versus drug-associated diabetes mellitus.一家艾滋病诊所中的严重高血糖:既往存在的糖尿病与药物相关糖尿病
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jan 1;17(1):46-50. doi: 10.1097/00042560-199801010-00007.

引用本文的文献

1
Metabolic Health Consequences of Switching to the Bictegravir/Emtricitabine/Tenofovir Alafenamide and Dolutegravir Plus Lamivudine Regimens in Virologically Suppressed People Living with HIV Aged > 40 Years: A Retrospective Real-World Study.40岁以上病毒学抑制的HIV感染者换用比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺和多替拉韦加拉米夫定方案的代谢健康后果:一项回顾性真实世界研究
Infect Drug Resist. 2025 May 29;18:2703-2716. doi: 10.2147/IDR.S516775. eCollection 2025.
2
Prevalence and factors associated with hyperglycemia among persons living with HIV/AIDS on dolutegravir-based antiretroviral therapy in Uganda.乌干达接受基于多替拉韦的抗逆转录病毒治疗的艾滋病毒/艾滋病感染者中高血糖的患病率及相关因素
Ther Adv Infect Dis. 2024 Sep 10;11:20499361241272630. doi: 10.1177/20499361241272630. eCollection 2024 Jan-Dec.
3

本文引用的文献

1
Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.1046 例接受联合抗逆转录病毒治疗的 HIV 感染者的 10 年糖尿病发病率。
AIDS. 2012 Jan 28;26(3):303-14. doi: 10.1097/QAD.0b013e32834e8776.
2
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study.HIV 感染者的发病率和老龄化:瑞士 HIV 队列研究。
Clin Infect Dis. 2011 Dec;53(11):1130-9. doi: 10.1093/cid/cir626. Epub 2011 Oct 13.
3
Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study.
Serum Lipid Profiles, Blood Glucose, and High-Sensitivity C-Reactive Protein Levels Among People Living with HIV Taking Dolutegravir and Ritonavir-Boosted Atazanavir-Based Antiretroviral Therapy at Jimma University Medical Center, Southwest Ethiopia, 2021.2021年埃塞俄比亚西南部吉马大学医学中心接受多替拉韦及利托那韦增效阿扎那韦抗逆转录病毒治疗的HIV感染者的血脂谱、血糖及高敏C反应蛋白水平
HIV AIDS (Auckl). 2024 Feb 12;16:17-32. doi: 10.2147/HIV.S430310. eCollection 2024.
4
The prevalence of hyperglycemia and its impact on mortality among people living with HIV in Georgia.格鲁吉亚 HIV 感染者中高血糖的流行情况及其对死亡率的影响。
PLoS One. 2022 Oct 27;17(10):e0276749. doi: 10.1371/journal.pone.0276749. eCollection 2022.
5
Derangement of Liver Enzymes, Hyperglycemia, Anemia, and Associated Factors among HIV-Infected Patients Treated with Tenofovir Disoproxil Fumarate-Based Regimen in Ethiopia: A Prospective Cohort Study.在接受富马酸替诺福韦二吡呋酯方案治疗的埃塞俄比亚 HIV 感染患者中,肝酶紊乱、高血糖、贫血及其相关因素的前瞻性队列研究。
Biomed Res Int. 2021 Jun 16;2021:6613519. doi: 10.1155/2021/6613519. eCollection 2021.
6
HIV and Aging in Mainland China: Implications for Control and Prevention Research.中国内地的艾滋病毒与老龄化:对控制和预防研究的影响。
Curr HIV/AIDS Rep. 2019 Dec;16(6):439-447. doi: 10.1007/s11904-019-00473-2.
7
Prevalence and determinants of selected cardio-metabolic risk factors among people living with HIV/AIDS and receiving care in the South West Regional Hospitals of Cameroon: a cross-sectional study.喀麦隆西南地区医院接受治疗的艾滋病毒/艾滋病患者中特定心血管代谢危险因素的患病率及决定因素:一项横断面研究
BMC Res Notes. 2018 May 16;11(1):305. doi: 10.1186/s13104-018-3444-0.
8
International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK.2016年10月23日至26日于英国格拉斯哥举行的HIV感染药物治疗国际大会。
J Int AIDS Soc. 2016 Oct 23;19(8(Suppl 7)):21487. doi: 10.7448/IAS.19.8.21487. eCollection 2016.
9
Human Immunodeficiency Virus and Risk of Type 2 Diabetes in a Large Adult Cohort in Jos, Nigeria.尼日利亚乔斯市一个大型成年队列中的人类免疫缺陷病毒与2型糖尿病风险
Clin Infect Dis. 2016 Sep 15;63(6):830-5. doi: 10.1093/cid/ciw381. Epub 2016 Jun 15.
10
Diabetes mellitus and impaired fasting glucose in ART-naïve patients with HIV-1, HIV-2 and HIV-1/2 dual infection in Guinea-Bissau: a cross-sectional study.几内亚比绍未接受抗逆转录病毒治疗的HIV-1、HIV-2和HIV-1/2双重感染患者中的糖尿病和空腹血糖受损:一项横断面研究。
Trans R Soc Trop Med Hyg. 2016 Apr;110(4):219-27. doi: 10.1093/trstmh/trw017.
早期启动抗逆转录病毒治疗和增加治疗覆盖率对中国 HIV 相关死亡率的影响:一项全国性观察性队列研究。
Lancet Infect Dis. 2011 Jul;11(7):516-24. doi: 10.1016/S1473-3099(11)70097-4.
4
Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems.HIV-1感染及高效抗逆转录病毒治疗中的脂质代谢与心血管风险:当前及未来问题
Cholesterol. 2010;2010:271504. doi: 10.1155/2010/271504. Epub 2010 Oct 31.
5
Management of metabolic complications and cardiovascular risk in HIV-infected patients.HIV 感染者代谢并发症及心血管风险的管理。
AIDS Rev. 2010 Oct-Dec;12(4):231-41.
6
Prevalence of diabetes among men and women in China.中国男性和女性糖尿病患病率。
N Engl J Med. 2010 Mar 25;362(12):1090-101. doi: 10.1056/NEJMoa0908292.
7
Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).糖尿病、已患冠心病以及感染人类免疫缺陷病毒患者发生后续冠心病事件的风险:抗逆转录病毒药物不良事件数据收集研究(D:A:D研究)
Circulation. 2009 Feb 17;119(6):805-11. doi: 10.1161/CIRCULATIONAHA.108.790857. Epub 2009 Feb 2.
8
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy.HIV感染患者心血管疾病的流行病学证据及其与高效抗逆转录病毒治疗的关系。
Circulation. 2008 Jul 8;118(2):e29-35. doi: 10.1161/CIRCULATIONAHA.107.189624. Epub 2008 Jun 19.
9
Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.HIV感染患者新发糖尿病的发病率及危险因素:抗HIV药物不良事件数据收集(D:A:D)研究
Diabetes Care. 2008 Jun;31(6):1224-9. doi: 10.2337/dc07-2013. Epub 2008 Feb 11.
10
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.瑞士HIV队列研究中与HIV感染参与者2型糖尿病发病率相关的因素。
Clin Infect Dis. 2007 Jul 1;45(1):111-9. doi: 10.1086/518619. Epub 2007 May 21.